{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:51:53Z","timestamp":1772211113906,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trim.2024.102135","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:37:57Z","timestamp":1728016677000},"page":"102135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review"],"prefix":"10.1016","volume":"87","author":[{"given":"Moazzam","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Atif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Kashif","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zouina","family":"Sarfraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fizza","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Brownback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nausheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil H.","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"McGuirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umair","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.trim.2024.102135_bb0005","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.trim.2024.102135_bb0010","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.trim.2024.102135_bb0015","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/s41409-021-01274-1","article-title":"Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality","volume":"56","author":"Ramdial","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2024.102135_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbmt.2019.09.034","article-title":"Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Wenger","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.trim.2024.102135_bb0025","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.trim.2024.102135_bb0030","series-title":"Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation","first-page":"221","article-title":"Idiopathic pneumonia syndrome","author":"Criner","year":"2023"},{"issue":"3","key":"10.1016\/j.trim.2024.102135_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00005792-198805000-00004","article-title":"Interstitital pneumonitis after allogeneic bone marrow transplantation: nine-year experience at a single institution","volume":"67","author":"Wingard","year":"1988","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.trim.2024.102135_bb0040","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bbmt.2017.07.019","article-title":"Etanercept and corticosteroid therapy for the treatment of late-onset idiopathic pneumonia syndrome","volume":"23","author":"Thompson","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2024.102135_bb0045","series-title":"Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation","first-page":"403","article-title":"Pulmonary and critical care considerations in pediatric hematopoietic stem cell transplantation patient","author":"Ktena","year":"2023"},{"issue":"11","key":"10.1016\/j.trim.2024.102135_bb0050","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/1744666X.2023.2249230","article-title":"Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease","volume":"19","author":"Algeri","year":"2023","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.trim.2024.102135_bb0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","article-title":"Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following ruxolitinib bridge therapy and transplantation","volume":"41","author":"Kayaoglu","year":"2021","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2024.102135_bb0060","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00185-2022","article-title":"Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions","volume":"8","author":"Glanville","year":"2022","journal-title":"ERJ Open Research"},{"issue":"6","key":"10.1016\/j.trim.2024.102135_bb0065","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbmt.2014.02.026","volume":"20","author":"Yanik","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.trim.2024.102135_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5242","article-title":"Successful ruxolitinib administration for a patient with steroid-refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: a case report and literature review","volume":"9","author":"Tomomasa","year":"2021","journal-title":"Clin. Case Reports"},{"issue":"8","key":"10.1016\/j.trim.2024.102135_bb0075","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2003-05-1597","article-title":"Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.trim.2024.102135_bb0080","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/10428194.2022.2057486","article-title":"Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation","volume":"63","author":"Tamaki","year":"2022","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.trim.2024.102135_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/trf.13361","article-title":"The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type","volume":"56","author":"Vande Vusse","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.trim.2024.102135_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbmt.2014.09.019","article-title":"TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint pediatric blood and marrow transplant consortium and Children's oncology group study (ASCT0521)","volume":"21","author":"Yanik","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.trim.2024.102135_bb0095","first-page":"3073","article-title":"The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation","volume":"112","author":"Yanik","year":"2008","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6","key":"10.1016\/j.trim.2024.102135_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0609.2008.01149.x","article-title":"Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Zhu","year":"2008","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.trim.2024.102135_bb0105","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.bbmt.2015.11.366","article-title":"Biomarkers for idiopathic pneumonia syndrome (IPS) after hematopoietic cell transplantation (HCT): comparison with viral infectious pneumonia","volume":"22","author":"Seo","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"24","key":"10.1016\/j.trim.2024.102135_bb0110","first-page":"3789","article-title":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies","volume":"125","author":"Seo","year":"2015","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.trim.2024.102135_bb0115","series-title":"The Impact of Soluble Tumor Necrosis Factor Receptor: Etanercept (Enbrel (R)) on the Treatment of Idiopathic Pneumonia Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation","author":"Yanik","year":"2008"},{"issue":"5","key":"10.1016\/j.trim.2024.102135_bb0120","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41409-019-0636-8","article-title":"Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Bondeelle","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2024.102135_bb0125","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000520824","article-title":"Late-onset, noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation: a nationwide cohort study of long-term survivors","volume":"101","author":"Myrdal","year":"2022","journal-title":"Respiration"},{"issue":"9","key":"10.1016\/j.trim.2024.102135_bb0130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3390\/children10091535","article-title":"Hematopoietic stem cells transplant (HSCT)-related chronic pulmonary diseases: an overview","volume":"10","author":"Traunero","year":"2023","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.trim.2024.102135_bb0135","doi-asserted-by":"crossref","first-page":"A598","DOI":"10.1016\/j.chest.2021.07.573","article-title":"Late-onset idiopathic pneumonia syndrome after hematopoietic cell transplantation","volume":"160","author":"Wegner Wippel","year":"2021","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.trim.2024.102135_bb0140","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1016\/j.transproceed.2005.10.101","article-title":"Etanercept therapy for late-onset idiopathic pneumonia syndrome after Nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Tun","year":"2005","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.trim.2024.102135_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/17476348.2019.1557049","article-title":"Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Bondeelle","year":"2019","journal-title":"Expert Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.trim.2024.102135_bb0150","first-page":"101","article-title":"Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis","volume":"82","author":"Shankar","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"issue":"156","key":"10.1016\/j.trim.2024.102135_bb0155","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2019","article-title":"Noninfectious pulmonary complications of haematopoietic stem cell transplantation","volume":"29","author":"Haider","year":"2020","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.trim.2024.102135_bb0160","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/jcm12062149","article-title":"The development of new agents for post-hematopoietic stem cell transplantation non-infectious complications in children","volume":"12","author":"Ilan","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.trim.2024.102135_bb0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2018.09.002","article-title":"Influence of total body irradiation dose rate on idiopathic pneumonia syndrome in acute leukemia patients undergoing allogeneic hematopoietic cell transplantation","volume":"103","author":"Gao","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.trim.2024.102135_bb0170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1513\/AnnalsATS.202001-006OT","article-title":"Pulmonary complications of pediatric hematopoietic cell transplantation. A National Institutes of Health workshop summary","volume":"18","author":"Tamburro","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.trim.2024.102135_bb0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtct.2022.03.015","article-title":"Noninfectious pulmonary toxicity after allogeneic hematopoietic cell transplantation","volume":"28","author":"Patel","year":"2022","journal-title":"Transplantation and cellular therapy"},{"key":"10.1016\/j.trim.2024.102135_bb0180","series-title":"Orphan Lung Diseases: A Clinical Guide to Rare Lung Disease","first-page":"705","article-title":"Pulmonary manifestations of hematological malignancies: Focus on pulmonary chronic graft-versus-host disease","author":"Samy","year":"2023"},{"issue":"1","key":"10.1016\/j.trim.2024.102135_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5603\/ARM.2020.0081","article-title":"Guidelines of the polish respiratory society for diagnosis and treatment of idiopathic pulmonary fibrosis","volume":"88","author":"Piotrowski","year":"2020","journal-title":"Advances in Respiratory Medicine"},{"issue":"5","key":"10.1016\/j.trim.2024.102135_bb0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/17476348.2021.1887734","article-title":"A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective","volume":"15","author":"Ali","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"issue":"11","key":"10.1016\/j.trim.2024.102135_bb0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2023021414","article-title":"How I manage acute respiratory failure in patients with hematological malignancies","volume":"143","author":"Azoulay","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.trim.2024.102135_bb0200","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/TP.0b013e31820c85fa","article-title":"Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients","volume":"91","author":"Solh","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2024.102135_bb0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s41030-023-00227-x","article-title":"Systemic corticosteroids for treating respiratory diseases: less is better, but\u2026 when and how is it possible in real life?","volume":"9","author":"Melani","year":"2023","journal-title":"Pulmonary Therapy"},{"issue":"7","key":"10.1016\/j.trim.2024.102135_bb0210","doi-asserted-by":"crossref","first-page":"103332","DOI":"10.1016\/j.autrev.2023.103332","article-title":"Tumor necrosis factor-\u03b1 inhibitor-related immune disorders","volume":"22","author":"De Stefano","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.trim.2024.102135_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838449","article-title":"BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis","volume":"13","author":"Herrmann","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.trim.2024.102135_bb0220","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1158\/1078-0432.CCR-19-3322","article-title":"Association of anti-TNF with decreased survival in steroid refractory ipilimumab and anti-PD1\u2013treated patients in the Dutch melanoma treatment registry","volume":"26","author":"Verheijden","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.trim.2024.102135_bb0225","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/bmt.2011.260","article-title":"High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after Allo-SCT","volume":"47","author":"Tizon","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2024.102135_bb0230","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/ph15030374","article-title":"New applications of JAK\/STAT inhibitors in pediatrics: current use of ruxolitinib","volume":"15","author":"Marcuzzi","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.trim.2024.102135_bb0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.trim.2024.102135_bb0240","first-page":"2435","article-title":"Lung parenchyma-derived IL-6 promotes IL-17A\u2013dependent acute lung injury after allogeneic stem cell transplantation","volume":"125","author":"Varelias","year":"2015","journal-title":"Blood, The Journal of the American Society of Hematology"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T03:54:22Z","timestamp":1732593262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327424001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S0966327424001515"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102135","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102135"}}